Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region
Franco Barrile, Céline M’Kadmi, Pablo N. De Francesco, et al.
Molecular and Cellular Endocrinology (2019) Vol. 498, pp. 110573-110573
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men
Christoffer Hagemann, Malene S. Jensen, Stephanie Holm, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 4, pp. 100582-100582
Open Access | Times Cited: 48
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
Kripa Shankar, Nathan P. Metzger, Omprakash Singh, et al.
Molecular Metabolism (2021) Vol. 53, pp. 101327-101327
Open Access | Times Cited: 53
A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice
Kripa Shankar, Nathan P. Metzger, Connor Lawrence, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101950-101950
Open Access | Times Cited: 6
LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity
Xuehan Lu, Lili Huang, Zhengxiang Huang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 37
Regulation of LEAP2 by insulin and glucagon in mice and humans
Valdemar Brimnes Ingemann Johansen, Anna Katrina Jógvansdóttir Gradel, Stephanie Kjærulff Holm, et al.
Cell Reports Medicine (2025), pp. 101996-101996
Open Access
Metabolic insights from a GHSR-A203E mutant mouse model
Lola Torz, Sherri Osborne‐Lawrence, Juan A. Rodriguez, et al.
Molecular Metabolism (2020) Vol. 39, pp. 101004-101004
Open Access | Times Cited: 37
THE INTRIGUING LIGAND-DEPENDENT AND LIGAND-INDEPENDENT ACTIONS OF THE GROWTH HORMONE SECRETAGOGUE RECEPTOR ON REWARD-RELATED BEHAVIORS
María Paula Cornejo, Emilio Román Mustafá, Franco Barrile, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 120, pp. 401-416
Closed Access | Times Cited: 37
Circulating ghrelin crosses the blood-cerebrospinal fluid barrier via growth hormone secretagogue receptor dependent and independent mechanisms
Maia Uriarte, Pablo N. De Francesco, Gimena Fernández, et al.
Molecular and Cellular Endocrinology (2021) Vol. 538, pp. 111449-111449
Closed Access | Times Cited: 30
The ups and downs of growth hormone secretagogue receptor signaling
María Paula Cornejo, Emilio Román Mustafá, Daniela Cassano, et al.
FEBS Journal (2021) Vol. 288, Iss. 24, pp. 7213-7229
Open Access | Times Cited: 26
LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling
Emilio Román Mustafá, Santiago Cordisco González, Marjorie Damian, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline
Jing Tian, Lan Guo, Tienju Wang, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 8
MOSPD2 is a receptor mediating the LEAP-2 effect on monocytes/macrophages in a teleost, <i>Boleophthalmus pectinirostris</i>
Changhong Li, Jie Chen, Li Nie, et al.
动物学研究 (2020) Vol. 41, Iss. 6, pp. 644-655
Open Access | Times Cited: 21
Dopamine Receptor Type 2 and Ghrelin Receptor Coexpression Alters CaV2.2 Modulation by G Protein Signaling Cascades
Santiago Cordisco González, Emilio Román Mustafá, Silvia Susana Rodríguez, et al.
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 1, pp. 3-13
Open Access | Times Cited: 20
Identifying key residues and key interactions for the binding of LEAP2 to receptor GHSR1a
Hao‐Zheng Li, Li‐Li Shou, Xiao‐Xia Shao, et al.
Biochemical Journal (2020) Vol. 477, Iss. 17, pp. 3199-3217
Open Access | Times Cited: 19
Involvement of POMC neurons in LEAP2 regulation of food intake and body weight
Guangpin Chu, Hualing Peng, Nana Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
Plasma LEAP-2 Following a Low-Calorie Diet with or without Interval Exercise in Women with Obesity
Tristan J. Ragland, Steven K. Malin
Nutrients (2023) Vol. 15, Iss. 3, pp. 655-655
Open Access | Times Cited: 6
Systemic Ghrelin Treatment Induces Rapid, Transient, and Asymmetric Changes in the Metabolic Activity of the Mouse Brain
Pablo N. De Francesco, Gimena Fernández, Maia Uriarte, et al.
Neuroendocrinology (2022) Vol. 113, Iss. 1, pp. 64-79
Open Access | Times Cited: 10
Growth hormone secretagogue receptor signaling in the supramammillary nucleus targets nitric oxide-producing neurons and controls recognition memory in mice
Julieta Paola Aguggia, María Paula Cornejo, Gimena Fernández, et al.
Psychoneuroendocrinology (2022) Vol. 139, pp. 105716-105716
Closed Access | Times Cited: 8
Surfmer versus Polymer Effect toward Solubilization and Stabilization of Membrane Proteins
Floriane Mangin, Vinay Chauhan, Pierre Guillet, et al.
ACS Applied Polymer Materials (2024) Vol. 6, Iss. 6, pp. 3139-3149
Closed Access | Times Cited: 1
GHSR in a Subset of GABA Neurons Controls Food Deprivation-Induced Hyperphagia in Male Mice
María Paula Cornejo, Gimena Fernández, Agustina Cabral, et al.
Endocrinology (2024) Vol. 165, Iss. 7
Closed Access | Times Cited: 1
Satiety Hormone LEAP2 After Low-Calorie Diet With/Without Endobarrier Insertion in Obesity and Type 2 Diabetes Mellitus
Mimoza Emini, Raghav Bhargava, Madhawi Aldhwayan, et al.
Journal of the Endocrine Society (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain
Camila Saenz, Gimena Fernández, Ramiro E. Llovera, et al.
Brain Structure and Function (2024) Vol. 230, Iss. 1
Open Access | Times Cited: 1
Ghrelin system in Alzheimer's disease
Jing Tian, Tienju Wang, Heng Du
Current Opinion in Neurobiology (2022) Vol. 78, pp. 102655-102655
Open Access | Times Cited: 7
A Decade’s Progress in the Development of Molecular Imaging Agents Targeting the Growth Hormone Secretagogue Receptor
Marina D. Childs, Leonard G. Luyt
Molecular Imaging (2020) Vol. 19
Open Access | Times Cited: 8
Constitutive activity of the dopamine (D5) receptor, highly expressed in CA1 hippocampal neurons, selectively reduces CaV3.2 and CaV3.3 currents
Emilio Román Mustafá, Clara Inés McCarthy, Andrea Estefanía Portales, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 9, pp. 1210-1231
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top